AH

Aimei Health Technology Co., Ltd

AFJK·NASDAQ

$40.87

-5.0%
Financial ServicesShell Companies

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$250.20M
EPS0.1700
P/E Ratio240.41
Earnings Date05/04/2026
a

Aimei Health Technology Co., Ltd Street Expectations Map

AFJK · NASDAQ

No Target Data

No analyst price targets available for afjk.

a

Aimei Health Technology Co., Ltd Forward Estimates of Revenue

AFJK · NASDAQ
Latest Revenue
0.00
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Forward Estimates of Net Income

AFJK · NASDAQ
Latest Net Income
1.06M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Forward Estimates of EPS

AFJK · NASDAQ
Latest EPS
0.17
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Forward Estimates of EBIT

AFJK · NASDAQ
Latest EBIT
-835.76K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Forward Estimates of EBITDA

AFJK · NASDAQ
Latest EBITDA
-835.76K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Forward Estimates of SG&A Expense

AFJK · NASDAQ
Latest SG&A Expense
835.76K
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

a

Aimei Health Technology Co., Ltd Insider Positioning

AFJK · NASDAQ

During the last 12 months, there has been no insider trading activity reported for AFJK.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Neutral

No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.

Insider Participation

No Activity

No insider trading activity reported from any insiders in the past year.